v3.26.1
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes

Note 9 – Income Taxes

 

The domestic and foreign components of net loss before income taxes are as follows:

 

(In thousands)   2025     2024  
   

For the Years Ended
December 31,

(In thousands)   2025     2024  
Domestic   $ (19,472   $ (21,819
Foreign     -       -  
Net loss before income taxes   $ (19,472   $ (21,819

 

The following summarizes the Company’s income tax provision (benefit):

 

(In thousands)  2025   2024 
   For the Years Ended
December 31,
 
(In thousands)  2025   2024 
Federal:          
Current  $-   $- 
Deferred   (3,174)   (4,030)
           
State and local:          
Current   -    - 
Deferred   (1,069)   (1,393)
Federal, State and Local, Tax Expense   (4,243)   (5,423)
Change in valuation allowance   4,243    5,423 
Income tax provision (benefit)  $-   $- 

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures by requiring more granular disaggregation in the effective tax rate (“ETR”) reconciliation and providing expanded information regarding income taxes paid, categorized by jurisdiction. The Company adopted the provisions of ASU 2023-09 on a prospective basis effective January 1, 2025.

 

 

In accordance with this guidance, the following table provides a disaggregated reconciliation of the Company’s effective income tax rate to the U.S. statutory federal income tax rate:

 

   Percentage  

Amount

(In thousands)

 
   For the Year Ended
December 31, 2025
 
   Percentage  

Amount

(In thousands)

 
Tax benefit at federal statutory rate   21.0%  $(4,089)
State taxes, net of federal benefit   -    - 
Foreign tax effects   -    - 
Effects of changes in tax laws or rates enacted   -    - 
Effect of cross-border tax laws   -    - 
Tax credits:          
Research and development costs   -    - 
Changes in valuation allowance   (16.3)%   3,174 
Nontaxable or nondeductible items:          
Stock-based compensation   (1.9)%   373 
Others   (0.5)%   90 
    3.8      
Changes in unrecognized tax benefits   -    - 
Other adjustments:          
Stock-based compensation true-up   (2.5)%   486 
Other adjustments   0.2%   (34)
    (0.1      
    (0.5      
Effective income tax   0.0%  $- 

 

The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective tax rate for the year ended December 31, 2024 is as follows in accordance with the guidance prior to adoption of ASU 2023-09:

 

   For the Year Ended
December 31,
 
   2024  
Tax benefit at federal statutory rate   (21.0 )%
State taxes, net of federal benefit   (7.0 )%
Nondeductible compensation   3.8 %
Permanent differences   (0.1 )%
True up adjustments   (0.5 )%
Change in valuation allowance   24.8 %
Effective income tax rate   0.0 %

 

The Company’s state and local income tax expense is primarily driven by its operations in California. For the year ended December 31, 2025, California represents greater than 50% of the state and local income tax component of the effective tax rate reconciliation. No other individual state or local jurisdiction accounted for more than 50% of the aggregate state and local tax effect for the year ended December 31, 2025.

 

Significant components of the Company’s deferred tax assets are as follows:

  

(In thousands)  2025   2024 
  

For the Years Ended

December 31,

 
(In thousands)  2025   2024 
Deferred tax assets:          
Net operating loss carryforwards  $28,054   $22,163 
Research and development credit carryforwards   186    186 
Research and development expense   3,845    5,347 
Intangible assets   202    190 
Operating lease liability   196    298 
Stock-based compensation   1,942    2,245 
Impairment loss   137    137 
Property and equipment   68    25 
Unrealized loss on short-term investments   110    6 
Total gross deferred tax assets   34,740    30,597 
Deferred tax liabilities          
Operating lease asset   (183)   (282)
Unrealized gain on short-term investments   -    - 
Property and equipment   -    - 
Total net deferred tax assets   34,557    30,315 
Less: valuation allowance   (34,557)   (30,315)
Total deferred tax assets  $-   $- 

 

 

On July 4, 2025 the One Big Beautiful Bill Act, or OBBBA, was enacted. The legislation includes several changes to the U.S. federal corporate income tax law, among other things, reinstating 100% bonus depreciation on qualified fixed assets, immediate expensing of domestic research and development expenditures, and favorable rules for determining the limitation on business interest expense. These changes were retroactively enacted for tax years beginning after December 31, 2024 with certain provisions effective after January 19, 2025 and were reflected in the income tax provision for the year ended December 31, 2025. The provisions of the OBBBA did not have a material impact on the effective income tax rate.

 

ASC 740 requires that the tax benefit of net operating losses, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is “more likely than not.” Realization of any future tax benefit is dependent on the Company’s ability to generate sufficient taxable income within the carryforward period. Because of the Company’s history of operating losses, management believes that recognition of the deferred tax assets arising from the above listed future tax benefits is currently not more likely than not to be realized and, accordingly, has provided a full valuation allowance. The valuation allowance increased by $4.2 million and $5.4 million during the years ended December 31, 2025 and 2024, respectively. 

 

As of December 31, 2025 and 2024, the Company net operating loss carryforwards for federal income tax purposes of approximately $95.6 million and $72.2 million, respectively. Of this, pre-2018 federal NOLs of approximately $12.0 million may be carried forward for twenty years and begin to expire in 2029. The remaining post 2018 federal NOLs of approximately $83.6 million can be carried forward indefinitely and could be used to offset up to 80% of taxable income in all the future years.

 

As of December 31, 2025 and 2024, the Company had net operating loss carryforwards for state income tax purposes of approximately $114.0 million and $97.7 million, respectively, which can be carried forward for twenty years and begin to expire in 2029.

 

To the extent the Company utilizes its NOL carryforward in the future, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service or state tax authorities of the future period tax return in which the attribute is utilized. The Company also has federal research and development tax credit carryforwards of approximately $0.2 million which begin to expire in 2027.

 

The utilization of the Company’s net operating loss carryforwards and research tax credit carryovers could be subject to annual limitations under Section 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”), due to ownership change limitations that may have occurred previously or that could occur in the future. These ownership changes limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382 and 383 of the Code, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percent points over a three-year period. The Company has not completed an analysis of an ownership change under Section 382 of the Code. To the extent that a study is completed and an ownership change is deemed to occur, the Company’s net operating losses and tax credits could be limited.

 

The Company files income tax returns in the U.S. federal jurisdiction as well as California and local jurisdictions and is subject to examination by those taxing authorities. The statute of limitations for assessment by the IRS and state tax authorities is open for tax years ending December 31, 2025, 2024, 2023, 2022 and 2021, although carryforward attributes that were generated for tax years prior to 2021 may still be adjusted upon examination by the IRS or state tax authorities if they either have been, or will be, used in future period. No tax audits were initiated during 2025 or 2024. For the fiscal year ended December 31, 2025, the Company did not make any payments for federal or state income taxes, net of refunds received.

 

 

Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of December 31, 2025 and 2024. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date. The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the statements of operations.